REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Novapharm, S.R.O. (Slovakia)

Main Activities: General Medical and Surgical Hospitals
Full name: Novapharm, S.R.O. Profile Updated: October 09, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Novapharm, s.r.o. in Bratislava is one of the members of the medical centres ProCare. Another centres are in Kosice, Banska Bystrica and Zvolen. The hospital offers medical health care services in the fields of chirurgy, neurology, urology, psychiatry, orthoptist and many others. In addition, in the area is a pharmacy.

Headquarters
Einsteinova, 23-25
Bratislava; Bratislavsky; Postal Code: 85101

Contact Details: Purchase the Novapharm, S.R.O. report to view the information.

Website: http://www.znap.sk

Basic Information
Total Employees:
Purchase the Novapharm, S.R.O. report to view the information.
Outstanding Shares:
Purchase the Novapharm, S.R.O. report to view the information.
Registered Capital:
Purchase the Novapharm, S.R.O. report to view the information.
Incorporation Date:
June 28, 1999
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Legal Representative
Ownership Details
Purchase this report to view the information.
85%
Purchase this report to view the information.
15%
Company Performance
Financial values in the chart are available after Novapharm, S.R.O. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency EUR. Absolute financial data is included in the purchased report.
Net sales revenue
-22.25%▼
Total operating revenue
3.47%▲
Operating profit (EBIT)
96.43%▲
EBITDA
43.16%▲
Net Profit (Loss) for the Period
88.43%▲
Total assets
88.38%▲
Total equity
102.63%▲
Operating Profit Margin (ROS)
5.26%▲
Net Profit Margin
3.93%▲
Return on Equity (ROE)
-0.61%▼
Debt to Equity Ratio
0.04%▲
Quick Ratio
0.85%▲
Cash Ratio
0%

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo